Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;220(7):457-458.
doi: 10.1016/j.rce.2020.06.003. Epub 2020 Jun 12.

[Ivermectin in COVID-19. Argumentun ad ignorantiam?]

[Article in Spanish]
Y Carlosama-Rosero  1
Affiliations

[Ivermectin in COVID-19. Argumentun ad ignorantiam?]

[Article in Spanish]
Y Carlosama-Rosero. Rev Clin Esp. 2020 Oct.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • [Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?].
    López Reboiro ML, Sardiña González C, López Castro J. López Reboiro ML, et al. Rev Clin Esp. 2020 Oct;220(7):458. doi: 10.1016/j.rce.2020.06.011. Epub 2020 Jul 4. Rev Clin Esp. 2020. PMID: 33994569 Free PMC article. Spanish. No abstract available.
  • Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?
    López Reboiro ML, Sardiña González C, López Castro J. López Reboiro ML, et al. Rev Clin Esp (Barc). 2020 Oct;220(7):458. doi: 10.1016/j.rce.2020.06.011. Epub 2020 Jul 4. Rev Clin Esp (Barc). 2020. PMID: 32703528 Free PMC article. No abstract available.

References

    1. López Reboiro M.L., Sardiña González C., López Castro J. COVID-19 y Argumentum ad ignorantiam o «no todo vale». Rev Clin Esp. 2020 doi: 10.1016/j.rce.2020.04.013. - DOI - PMC - PubMed
    1. Rajter JC, Sherman M, Fatteh N, Vogel F, Sacks J, Rajter J-J. ICON (Ivermectin in COvid Nineteen) study: Use of Ivermectin is Asssociated with Lower Mortality in Hospitalized Patientes with COVID 19. MedRxiv 2020:2020.06.06.20124461. 10.1016/j.rce.2020.06.003 - DOI - PMC - PubMed
    1. Victoria J. Ivermectina: sus múltiples usos, seguridad y toxicidad. Rev Chil Dermatol. 2010;26:358–368.
    1. Seguridad de los pacientes con COVID-19 en relación con el uso de medicamentos sin evidencia científica sobre su beneficio - OPS/OMS | Organización Panamericana de la Salud [consultado 24 May 2020]. Disponible en https://www.paho.org/es/documentos/seguridad-pacientes-con-covid-19-rela...